Updated Apr. 10, 2013 at 6:51 p.m.

Premium Lock GSK targets 'electroceuticals' for potential new therapies

Published: 2013-04-10 18:51:00
Updated: 2013-04-10 18:51:46

GSK GSK

GlaxoSmithKline wants to see if new treatments can be found in a new way - by targeting electrical signals in the body....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

page 1
sort order: oldest first | newest first
One way of applying stimulation could also be from micro-magnets. Work on that from Cleveland Clinic is being presented at the 11th Biennial World Congress on neuromodulation therapies, where GSK will deliver an invited talk and a high-level investment and innovation "summit" kicks off the event: http://www.newswise.com/articles/medical-device-summit-on-growth-in-neuromodulation. The cross-cutting meeting (http://www.neuromodulation.com/ins-congress) is presented by the International Neuromodulation Society.
page 1
sort order: oldest first | newest first

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll